ARTEMIS MEDICARE SERVICES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 216.5 INR | -0.96% |
|
+17.92% | +20.34% |
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's profit outlook over the next few years is a strong asset.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 34.95 times its estimated earnings per share for the ongoing year.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +20.34% | 355M | - | ||
| -31.86% | 13.83B | B+ | ||
| +4.98% | 11.94B | B+ | ||
| -6.31% | 11.44B | B | ||
| +11.39% | 10.94B | B+ | ||
| +29.71% | 8.71B | B | ||
| +19.71% | 7.58B | B- | ||
| -9.73% | 7.38B | A- | ||
| +7.33% | 6.4B | D | ||
| +14.60% | 4.34B | B+ |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- ARTEMISMED Stock
- ARTEMISMED Stock
- Ratings Artemis Medicare Services Limited
